FreeTheAI

Gensight Biologics SA

SIGHT · EURONEXT · EUR

€0.0779

−0.0024 −2.99%todayNot financial advice.

SIGHT Price chart 6M
Open
0.0802
Day range
0.0777 - 0.0802
52-week range
0.0715 - 0.2390
Volume
728.06K
Market cap
21.13M
P/E ratio
—
EPS
-0.08
Dividend yield
0.00%
Beta
0.22

Performance

W

−5.00%

1M

−30.32%

3M

−5.92%

6M

−11.28%

YTD

−26.79%

Y

−49.42%

5Y

−98.93%

All

−99.05%

In the news

  1. Oct 8

    GenSight Biologics Publishes Safety and Vision Data for GS030 Gene Therapy

    GenSight Biologics published peer-reviewed Phase 1/2 safety and exploratory visual data for its retinitis pigmentosa gene therapy, GS030.

    Company news

  2. Oct 7

    GenSight Biologics Warns of Going-Concern Risk as Cash Drops to 0.7 Million Euros

    Gensight Biologics SA warned of going-concern uncertainty after its cash fell to 0.7 million euros, prompting a search for urgent bridge financing.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/EURONEXT-SIGHT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Gensight Biologics SA (SIGHT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/EURONEXT-SIGHT">SIGHT stock price</a> by FreeTheAI Stocks</p>